Encompass Health (EHC) Short-term Investments (2009 - 2026)

Encompass Health has reported Short-term Investments for 14 years, with the latest figure at $52.9 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 95.93% year-over-year to $52.9 million; the trailing twelve-month figure through Mar 2026 stood at $52.9 million (up 95.93% YoY), and the FY2025 full-year result was $30.7 million, down 18.57% from the prior year.
• Short-term Investments for Q1 2026 stood at $52.9 million, up from $30.7 million in the prior quarter.
• The five-year high for Short-term Investments was $67.4 million in Q2 2022, with the low at $27.0 million in Q1 2025.
• Historically, Short-term Investments has averaged $41.0 million across 5 years, with a median of $38.3 million in 2024.
• Annual changes were most pronounced in 2022 — Short-term Investments tumbled 49.44% — and 2026, when it surged 95.93%.
• Encompass Health's Short-term Investments stood at $31.6 million in 2022, then gained by 11.08% to $35.1 million in 2023, then rose by 7.41% to $37.7 million in 2024, then slipped by 18.57% to $30.7 million in 2025, then surged by 72.31% to $52.9 million in 2026.
• The last three Short-term Investments figures came in at $52.9 million (Q1 2026), $30.7 million (Q4 2025), and $45.0 million (Q3 2025), per Business Quant data.